AQST
Aquestive Therapeutics, Inc.$3.96-0.09 (-2.10%)Prev Close$4.04·MCap$421.1M·P/E—·Vol1.66M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
20
$3.66M
◆
Net Activity
Net Seller
$3.66M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Aquestive Therapeutics, Inc. (AQST) has been exclusively selling, with 0 insider purchases totaling $0.00 and 20 insider sales totaling $3.66M. The most recent insider transaction was by Krop Julie (director), who sold $125.4K worth of shares on Jun 24, 2026. Aquestive Therapeutics, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $421.1M.
AQST Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Krop Julie | director | Sell | 25,000 | $5.02 | $125.4K | 0Exit |
| Jun 16, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.16 | $104.0K | 635,574 |
| May 18, 2026 | Barber Daniel | officer: President and CEO | Sell | 8,257 | $4.29 | $35.4K | 660,574 |
| Mar 11, 2026 | Barber Daniel | officer: President and CEO | Sell | 180,677 | $4.17 | $754.0K | 1,004,753 |
| Mar 11, 2026 | Boyd Peter E. | officer: Chief People Officer | Sell | 29,814 | $4.17 | $124.4K | 338,509 |
| Mar 11, 2026 | BRAENDER LORI J | officer: Chief Legal Officer | Sell | 40,102 | $4.17 | $167.3K | 442,879 |
| Mar 11, 2026 | Cioffi Melina | officer: SVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $105.6K | 274,867 |
| Mar 11, 2026 | Jung Cassie | officer: Chief Operating Officer | Sell | 45,791 | $4.17 | $191.1K | 274,980 |
| Mar 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 15,741 | $4.17 | $65.7K | 241,117 |
| Mar 11, 2026 | TOTH A ERNEST JR | officer: Chief Financial Officer | Sell | 58,254 | $4.17 | $243.1K | 376,112 |
| Dec 2, 2025 | Cioffi Melina | SVP, Regulatory Affairs | Sell | 2,083 | $5.93 | $12.4K | 0 |
| Oct 15, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $7.00 | $70.0K | 0 |
| Oct 15, 2025 | Jung Cassie | Chief Operating Officer | Sell | 67,575 | $7.01 | $473.7K | 0 |
| Oct 15, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 20,272 | $7.00 | $141.9K | 0 |
| Sep 26, 2025 | Barber Daniel | President and CEO | Sell | 91,343 | $6.03 | $551.2K | 0 |
| Sep 26, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $6.30 | $63.0K | 0 |
| Sep 19, 2025 | Barber Daniel | President and CEO | Sell | 400 | $6.00 | $2.4K | 0 |
| Sep 5, 2025 | Boyd Peter E. | See Remarks | Sell | 15,000 | $5.30 | $79.5K | 0 |
| Sep 4, 2025 | Jung Cassie | Chief Operating Officer | Sell | 62,180 | $5.00 | $310.9K | 0 |
| Aug 9, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.90 | $42.2K | 0 |
| Jun 9, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 2,714 | $3.54 | $9.6K | 0 |
| Mar 7, 2025 | Barber Daniel | President and CEO | Sell | 83,305 | $2.65 | $220.8K | 0 |
| Mar 7, 2025 | Boyd Peter E. | See Remark | Sell | 14,305 | $2.65 | $37.9K | 0 |
| Mar 7, 2025 | BRAENDER LORI J | Chief Legal Officer | Sell | 20,250 | $2.65 | $53.7K | 0 |
| Mar 7, 2025 | Jung Cassie | Chief Operating Officer | Sell | 17,540 | $2.64 | $46.2K | 0 |
| Mar 7, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 5,428 | $2.65 | $14.4K | 0 |
| Mar 7, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 8,115 | $2.65 | $21.5K | 0 |
| Mar 7, 2025 | TOTH A ERNEST JR | Chief Financial Officer | Sell | 18,929 | $2.65 | $50.2K | 0 |
| Mar 7, 2025 | Wargacki Stephen | Chief Science Officer | Sell | 32,862 | $2.63 | $86.6K | 0 |
| Nov 26, 2024 | Jung Cassie | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | 0 |
| Aug 9, 2024 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.43 | $37.1K | 0 |
| Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 50,000 | $6.00 | $300.0K | 0 |
| Mar 9, 2024 | Barber Daniel | President and CEO | Sell | 37,938 | $4.88 | $185.1K | 0 |
| Mar 9, 2024 | Boyd Peter E. | See Remark | Sell | 8,370 | $4.88 | $40.8K | 0 |
| Mar 9, 2024 | BRAENDER LORI J | SVP, General Counsel | Sell | 10,530 | $4.88 | $51.4K | 0 |
| Mar 9, 2024 | Jung Cassie | SVP, Operations | Sell | 9,432 | $4.88 | $46.0K | 0 |
| Mar 9, 2024 | TOTH A ERNEST JR | SVP, Chief Financial Officer | Sell | 11,705 | $4.88 | $57.1K | 0 |
| Mar 9, 2024 | Wargacki Stephen | SVP, Research & Development | Sell | 12,956 | $4.88 | $63.2K | 0 |
| Mar 8, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 30,895 | $5.13 | $158.5K | 0 |
| Mar 10, 2023 | Wargacki Stephen | SVP, Research & Development | Sell | 1,981 | $0.79 | $1.6K | 0 |
| Jun 14, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Jun 8, 2022 | Barber Daniel | Chief Executive Officer | Buy | 91,743 | $0.96 | $88.1K | 0 |
| Jun 8, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 2,293 | $0.96 | $2.2K | 0 |
| Jun 8, 2022 | BRAENDER LORI J | General Counsel | Buy | 13,761 | $0.96 | $13.2K | 0 |
| Jun 8, 2022 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Buy | 45,871 | $0.96 | $44.0K | 0 |
AQST Insider Buying Activity
The following table shows recent insider purchases of Aquestive Therapeutics, Inc. (AQST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Jun 8, 2022 | Barber Daniel | Chief Executive Officer | Buy | 91,743 | $0.96 | $88.1K | 0 |
| Jun 8, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 2,293 | $0.96 | $2.2K | 0 |
| Jun 8, 2022 | BRAENDER LORI J | General Counsel | Buy | 13,761 | $0.96 | $13.2K | 0 |
| Jun 8, 2022 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Buy | 45,871 | $0.96 | $44.0K | 0 |
AQST Insider Selling Activity
The following table shows recent insider sales of Aquestive Therapeutics, Inc. (AQST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Krop Julie | director | Sell | 25,000 | $5.02 | $125.4K | 0Exit |
| Jun 16, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.16 | $104.0K | 635,574 |
| May 18, 2026 | Barber Daniel | officer: President and CEO | Sell | 8,257 | $4.29 | $35.4K | 660,574 |
| Mar 11, 2026 | Barber Daniel | officer: President and CEO | Sell | 180,677 | $4.17 | $754.0K | 1,004,753 |
| Mar 11, 2026 | Boyd Peter E. | officer: Chief People Officer | Sell | 29,814 | $4.17 | $124.4K | 338,509 |
| Mar 11, 2026 | BRAENDER LORI J | officer: Chief Legal Officer | Sell | 40,102 | $4.17 | $167.3K | 442,879 |
| Mar 11, 2026 | Cioffi Melina | officer: SVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $105.6K | 274,867 |
| Mar 11, 2026 | Jung Cassie | officer: Chief Operating Officer | Sell | 45,791 | $4.17 | $191.1K | 274,980 |
| Mar 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 15,741 | $4.17 | $65.7K | 241,117 |
| Mar 11, 2026 | TOTH A ERNEST JR | officer: Chief Financial Officer | Sell | 58,254 | $4.17 | $243.1K | 376,112 |
| Dec 2, 2025 | Cioffi Melina | SVP, Regulatory Affairs | Sell | 2,083 | $5.93 | $12.4K | 0 |
| Oct 15, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $7.00 | $70.0K | 0 |
| Oct 15, 2025 | Jung Cassie | Chief Operating Officer | Sell | 67,575 | $7.01 | $473.7K | 0 |
| Oct 15, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 20,272 | $7.00 | $141.9K | 0 |
| Sep 26, 2025 | Barber Daniel | President and CEO | Sell | 91,343 | $6.03 | $551.2K | 0 |
| Sep 26, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $6.30 | $63.0K | 0 |
| Sep 19, 2025 | Barber Daniel | President and CEO | Sell | 400 | $6.00 | $2.4K | 0 |
| Sep 5, 2025 | Boyd Peter E. | See Remarks | Sell | 15,000 | $5.30 | $79.5K | 0 |
| Sep 4, 2025 | Jung Cassie | Chief Operating Officer | Sell | 62,180 | $5.00 | $310.9K | 0 |
| Aug 9, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.90 | $42.2K | 0 |
| Jun 9, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 2,714 | $3.54 | $9.6K | 0 |
| Mar 7, 2025 | Barber Daniel | President and CEO | Sell | 83,305 | $2.65 | $220.8K | 0 |
| Mar 7, 2025 | Boyd Peter E. | See Remark | Sell | 14,305 | $2.65 | $37.9K | 0 |
| Mar 7, 2025 | BRAENDER LORI J | Chief Legal Officer | Sell | 20,250 | $2.65 | $53.7K | 0 |
| Mar 7, 2025 | Jung Cassie | Chief Operating Officer | Sell | 17,540 | $2.64 | $46.2K | 0 |
| Mar 7, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 5,428 | $2.65 | $14.4K | 0 |
| Mar 7, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 8,115 | $2.65 | $21.5K | 0 |
| Mar 7, 2025 | TOTH A ERNEST JR | Chief Financial Officer | Sell | 18,929 | $2.65 | $50.2K | 0 |
| Mar 7, 2025 | Wargacki Stephen | Chief Science Officer | Sell | 32,862 | $2.63 | $86.6K | 0 |
| Nov 26, 2024 | Jung Cassie | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | 0 |
| Aug 9, 2024 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.43 | $37.1K | 0 |
| Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 50,000 | $6.00 | $300.0K | 0 |
| Mar 9, 2024 | Barber Daniel | President and CEO | Sell | 37,938 | $4.88 | $185.1K | 0 |
| Mar 9, 2024 | Boyd Peter E. | See Remark | Sell | 8,370 | $4.88 | $40.8K | 0 |
| Mar 9, 2024 | BRAENDER LORI J | SVP, General Counsel | Sell | 10,530 | $4.88 | $51.4K | 0 |
| Mar 9, 2024 | Jung Cassie | SVP, Operations | Sell | 9,432 | $4.88 | $46.0K | 0 |
| Mar 9, 2024 | TOTH A ERNEST JR | SVP, Chief Financial Officer | Sell | 11,705 | $4.88 | $57.1K | 0 |
| Mar 9, 2024 | Wargacki Stephen | SVP, Research & Development | Sell | 12,956 | $4.88 | $63.2K | 0 |
| Mar 8, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 30,895 | $5.13 | $158.5K | 0 |
| Mar 10, 2023 | Wargacki Stephen | SVP, Research & Development | Sell | 1,981 | $0.79 | $1.6K | 0 |
AQST Insiders
Schobel Alexander Mark
Chief Innovation/Tech Officer
Bought $44.0KSold $458.5K
3 tradesLast: Mar 15, 2024
Similar Stocks to AQST
VTRS
Viatris Inc.
$16.57+1.69%
$18.95B
ELAN
Elanco Animal Health Incorporated
$25.69+0.61%
$12.40B
AMRX
Amneal Pharmaceuticals, Inc.
$17.21+3.15%
$5.49B
INDV
Indivior Pharmaceuticals Inc
$41.08+2.10%
$5.02B
ANIP
ANI Pharmaceuticals, Inc.
$81.33+0.97%
$1.87B
HROW
Harrow Health, Inc.
$42.85+3.58%
$1.54B
PAHC
Phibro Animal Health Corporation
$33.87+2.51%
$1.34B
COLL
Collegium Pharmaceutical, Inc.
$36.30+3.66%
$1.14B